Abiopharma

🔍 Mackay Sean (Executive)

Company: STANDARD BIOTOOLS INC. (LAB)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 272,107 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 1,032,281.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 612,240 shares of Stock Option (Right to buy) at $0.9846 per share (Derivative)
  Date: 2026-03-20 | Code: A | Expires: 2036-03-20 | equity_swap_involved: false | shares_owned_after: 612,240.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents restricted stock units ("RSUs") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
• F2: The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.